Abigail S. Fleming
Abigail S. Fleming's purchase track record
Abigail S. Fleming has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/21/2025 | LINE | $17K | +13.4% | +23.0% | +13.2% |
| 7/26/2024 | LINE | $20K | -7.6% | -26.6% | +11.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Visteon faces price target cuts from Barclays, UBS, and Goldman Sachs. Three major banks recently lowered their price targets for Visteon, with Barclays cutting to $125, UBS to $107, and Goldman Sachs to $104. Despite these reductions, all three firms maintained their positive ratings on the stock. The moves come as the stock trades near its 52-week low, reflecting broader caution in the automotive supplier sector.
Transaction History
| LINE | ▼ Sell | Tax Withholding | 205 | $7K | 4/24/2026 | View on chart |
| LINE | ▼ Sell | Tax Withholding | 276 | $9K | 4/1/2026 | View on chart |
| LINE | ▲ Buy | Grant | 12,203 | $0 | 4/1/2026 | View on chart |
| LINE | ▼ Sell | Tax Withholding | 356 | $14K | 2/23/2026 | View on chart |
| LINE | ▲ Buy | Grant | 1,049 | $0 | 2/23/2026 | View on chart |
| LINE | ▲ Buy | Open Market | 500 | $17K | 11/21/2025 | View on chart |
| LINE | ▼ Sell | Tax Withholding | 253 | $14K | 4/24/2025 | View on chart |
| LINE | ▼ Sell | Other | 5 | $251 | 4/21/2025 | View on chart |
| LINE | ▲ Buy | Grant | 2,812 | $0 | 4/1/2025 | View on chart |
| LINE | ▼ Sell | Other | 4 | $248 | 1/21/2025 | View on chart |
| LINE | ▼ Sell | Other | 2 | $179 | 10/21/2024 | View on chart |
| LINE | ▲ Buy | Open Market | 250 | $20K | 7/26/2024 | View on chart |
| LINE | ▲ Buy | Grant | 658 | $0 | 7/26/2024 | View on chart |
| LINE | ▼ Sell | Tax Withholding | 189 | $15K | 7/26/2024 | View on chart |
| VC | ▲ Buy | Option Exercise | 156 | — | 3/15/2023 | View on chart |
| VC | ▼ Sell | Tax Withholding | 44 | $7K | 3/15/2023 | View on chart |
| VC | ▲ Buy | Option Exercise | 238 | — | 3/15/2023 | View on chart |
| VC | ▼ Sell | Tax Withholding | 69 | $11K | 3/15/2023 | View on chart |
| VC | ▼ Sell | Tax Withholding | 65 | $8K | 8/20/2022 | View on chart |
| VC | ▲ Buy | Option Exercise | 227 | — | 8/20/2022 | View on chart |
| VC | ▼ Sell | Tax Withholding | 53 | $5K | 3/15/2022 | View on chart |
| VC | ▲ Buy | Option Exercise | 156 | — | 3/15/2022 | View on chart |
| VC | ▲ Buy | Option Exercise | 227 | — | 8/20/2021 | View on chart |
| VC | ▼ Sell | Tax Withholding | 65 | $7K | 8/20/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Lineage Credit Rating Downgrade and Analyst Target Cuts
Fitch lowered Lineage’s rating to BBB with a stable outlook, matching a broader trend of analysts trimming price targets. Evercore and Scotiabank both cut their targets to $43 and $39 respectively, while the 25‑year partnership with BSF was extended. The stock sits near a key support level of $43.12 and has a low RSI of 26.4, indicating potential buying pressure.
Lineage Credit Rating Downgrade and Analyst Target Cuts. Fitch lowered Lineage’s rating to BBB with a stable outlook, matching a broader trend of analysts trimming price targets. Evercore and Scotiabank both cut their targets to $43 and $39 respectively, while the 25‑year partnership with BSF was extended. The stock sits near a key support level of $43.12 and has a low RSI of 26.4, indicating potential buying pressure.